GlassScriptPrepare for your visit
Carey O Bryan
Cardiovascular Disease · Newport Beach, CA · NPI 1912996356
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$717.68
in general payments reported to CMS, 2019-2025 · $191 in 2025
The $191 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Novartis Pharmaceuticals Corporation $398.92
- Janssen Pharmaceuticals, INC $85.25
- E.R. Squibb & Sons, L.L.C. $59.95
- Amgen INC. $47.96
- Medtronic Vascular, INC. $28.85
- Cvrx, INC. $24.86
Drugs and devices associated with these payments
Leqvio Entresto Repatha Barostim Neo System Farxiga Xarelto Camzyos Eliquis
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Carey O Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1295993/carey-o-bryan